5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.81▲ | 0.81▲ | 0.81▲ | 0.82▲ | 0.82▲ |
MA10 | 0.81▲ | 0.80▲ | 0.80▲ | 0.81▲ | 0.79▲ |
MA20 | 0.81▲ | 0.81▲ | 0.81▲ | 0.80▲ | 0.75▲ |
MA50 | 0.81▲ | 0.81▲ | 0.81▲ | 0.77▲ | 1.00▼ |
MA100 | 0.80▲ | 0.82▼ | 0.83▼ | 0.75▲ | 1.42▼ |
MA200 | 0.84▼ | 0.82▼ | 0.79▲ | 0.99▼ | 3.08▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.001▲ | 0.002▲ | -0.002▼ | 0.031▲ |
RSI | 53.737▲ | 53.786▲ | 53.556▲ | 53.561▲ | 48.447▼ |
STOCH | 84.177▲ | 77.988 | 77.988 | 61.385 | 58.036 |
WILL %R | -5.102▲ | -5.102▲ | -5.102▲ | -28.122 | -41.684 |
CCI | 76.976 | 92.527 | 92.527 | 153.837▲ | 61.164 |
Thursday, August 21, 2025 06:47 PM
Cue Energy Resources Limited ( ($AU:CUE) ) has provided an announcement. Cue Energy Resources Limited has announced a new dividend distribution of ...
|
Thursday, August 21, 2025 05:07 AM
BOSTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate ...
|
Friday, November 15, 2024 09:59 PM
Cue Biopharma (CUE) has disclosed a new risk, in the Share Price & Shareholder Rights category. Cue Biopharma faces a significant risk regarding its compliance with Nasdaq’s continued listing ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
22/08/25 | 0.82 | 0.85 | 0.788 | 0.826 | 172,800 |
21/08/25 | 0.79 | 0.8199 | 0.78 | 0.8114 | 86,460 |
20/08/25 | 0.81 | 0.82 | 0.77 | 0.8084 | 75,530 |
19/08/25 | 0.8021 | 0.8198 | 0.7945 | 0.816 | 34,284 |
18/08/25 | 0.83 | 0.83 | 0.782 | 0.8188 | 87,391 |
15/08/25 | 0.81 | 0.835 | 0.765 | 0.826 | 200,086 |
14/08/25 | 0.7987 | 0.82 | 0.78 | 0.79 | 29,072 |
13/08/25 | 0.81 | 0.84 | 0.76 | 0.8103 | 87,938 |
12/08/25 | 0.8065 | 0.835 | 0.7821 | 0.79 | 76,229 |
11/08/25 | 0.8354 | 0.85 | 0.781 | 0.8314 | 87,176 |
|
|
||||
|
|
||||
|
|